Hajer Ali Sinan on The Role of Fibrin-Related Biomarkers at IFRS Congress
Hajer Ali Sinan, Biomedical Engineering PhD Student at Rutgers University, shared on LinkedIn:
”Last week, I had the amazing opportunity to attend the International Fibrinogen Research Society (IFRS) in Corfu, Greece (a small, close-knit meeting filled with experts who live and breathe coagulation research).
I presented my work, “Predicting Trauma Mortality with Machine Learning: The Role of Fibrin-Related Biomarkers,” and I’m so honored to have received the IFRS/ISFP Congress Travel Award.
My research looks at how machine learning can uncover hidden patterns in blood biomarkers to better understand what’s happening inside the body after traumatic injury.
Since blood flow is quite literally what keeps us alive, I believe decoding its signals through data-driven methods can help clinicians make more informed decisions and ultimately improve patient outcomes.
This work was done under the mentorship of Dr. Valerie Tutwiler, PhD and in collaboration with Dr. Ioannis Androulakis.
I also got to attend with Rebecca Risman, PhD and Andrew Gosselin, meet inspiring scientists, and learn so much about the evolving field of coagulation research.
Some of my favorite parts:
• Learning from global experts in fibrinogen biochemistry, hemostasis, and clot mechanics
• Hearing about innovative approaches and emerging tools shaping coagulation research
• Connecting with amazing researchers, mentors, and potential collaborators!
• And of course… enjoying the beauty of Greece.”
Stay updated with Hemostasis Today.
-
Oct 26, 2025, 16:55ECTH 2025: 3 Unforgettable Days of Science and Shared Purpose
-
Oct 26, 2025, 16:35Ahmed Koriesh on Thrombolysis in Stroke Patients on DOACs
-
Oct 26, 2025, 15:39Lisa Murphy on Life After Stroke Sessions at WSC 2025
-
Oct 26, 2025, 15:21Patricia Simal Presented the Spanish National Health System's Stroke Strategy at WSC 2025
-
Oct 26, 2025, 14:32Paula Boldo on Sex-Stratified Genetic Risk of Stroke at WSC 2025
-
Oct 26, 2025, 15:04Nita Radhakrishnan and Colleagues on Inherited Haematological Conditions
-
Oct 26, 2025, 14:55Anirban Sen Gupta on Biosynthetic Blood Surrogates Current State-of-Art
-
Oct 26, 2025, 12:24Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini on Historical Treatments of DVT
-
Oct 24, 2025, 12:08Julián Alejandro Rivillas Compares Tenecteplase to Low-dose Alteplase: TRACE-5 Interim Phase II Results
-
Oct 24, 2025, 12:03Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 25, 2025, 09:32Sylaja Pn Wins 2025 WSO Presidential Award
-
Oct 25, 2025, 08:21Courtney Lawrence: Listen. Empower. Deliver. Save Lives!
-
Oct 25, 2025, 08:14Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
-
Oct 24, 2025, 11:28Louise Bannon and Thomas Reiser Thank World Thrombosis Day Supporters Around The World
-
Oct 24, 2025, 10:48Melanie Daniel Congratulates Mickael Rosa and Antoine Rauch on Winning Bernd R. Binder Prize